Breaking Finance News

A report released today by finnCap about Tristel PLC (LON:TSTL) raises the target price to 150.00GBX

Just yesterday Tristel PLC (LON:TSTL) traded -0.21% lower at 162.50GBX. Tristel PLC’s 50-day moving average is 145.58GBX and its two hundred day average is 124.75GBX. With the last stock price close up 27.99% relative to the two hundred day average, compared with the S&P 500 Index which has decreased -0.01% over the date range. Volume of trade was down over the average, with 46,410 shares of TSTL changing hands under the typical 76,206

In a report released on 10/17/2016 finnCap upped the price target of Tristel PLC (LON:TSTL) from 140.00GBX to 150.00GBX reporting a potential downside of -0.08%.

See Chart Below

Tristel PLC (LON:TSTL)

Tristel PLC has a 52 week low of 87.11GBX and a 52 week high of 169.00GBX with a P/E ratio of 42.02 The company’s market cap is currently 0 GBX.

About Tristel PLC (LON:TSTL)

Tristel plc is a United Kingdom-based manufacturer of infection prevention and contamination control products. The Company operates through three segments: Human Healthcare, Animal Healthcare and Contamination Control. The Human Healthcare segment is engaged in the manufacture, development and sale of infection control and hygiene products, which include products that are used for infection control in hospitals. The Human Healthcare segment's products are marketed under the brand, Tristel. The Animal Healthcare segment relates to manufacture and sale of disinfection and cleaning products into veterinary and animal welfare sectors. The Animal Healthcare segment's products are marketed under the brand, Anistel. The Contamination Control segment addresses the pharmaceutical and personal care product manufacturing industries. The Contamination Control segment's products are marketed under the brand, Crystel. Its other brands include Dermastel, Enzystel and Medistel.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *